Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Summary of Warrants Outstanding (Details)

v3.22.1
Stockholders' Equity - Summary of Warrants Outstanding (Details)
6 Months Ended
Feb. 28, 2022
$ / shares
shares
Number of shares  
Number of shares outstanding, beginning balance (in shares) | shares 9,592,085
Issued (in shares) | shares 22,470,104
Cancelled (in shares) | shares 0
Exercised (in shares) | shares (4,948,453)
Number of shares outstanding, ending balance (in shares) | shares 27,113,736
Number of shares exercisable (in shares) | shares 16,840,654
Weighted average remaining life (years)  
Weighted remaining life (years), beginning 4 years 8 months 12 days
Issued 4 years 8 months 12 days
(Cancelled) 0 years
(Exercised) 4 years 3 months 18 days
Weighted remaining life (years), ending 4 years 8 months 12 days
Weighted remaining life (years) exercisable 4 years 2 months 12 days
Weighted average exercise price  
Weighted average exercise prices, beginning (in dollars per share) | $ / shares $ 3.87
Issued (in dollars per share) | $ / shares 1.58
Cancelled (in dollars per share) | $ / shares 0
Exercised (in dollars per share) | $ / shares 1.2
Weighted average exercise prices, ending (in dollars per share) | $ / shares 2.83
Weighted average exercise price exercisable (in dollars per share) | $ / shares $ 0.95